My Account

Monday, December 23, 2024

Canada’s Politics and Government News Source Since 1989

The building blocks of drug coverage reforms in Canada

In the fragmented system, we don't even have access to data on prescribed drugs to assess if physicians’ prescribing habits are in line with best medical evidence, or if they are simply the results of drug companies’ promotional campaigns.

Opinion
BY MARC-ANDRé GAGNON
April 29, 2019

Opinion | BY MARC-ANDRé GAGNON | April 29, 2019

FOLLOW THE HILL TIMES:

Want to make sure your whole office has the full Hill Times experience?

We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.

More Opinion

Chrystia Freeland’s resignation changes nothing

OpinionBY EVAN SOTIROPOULOS

A unique research and innovation partnership celebrates three decades: South Africa and Canada move forward with a renewed vision

OpinionBY PAUL DUFOUR, MICHAEL KAHN

Tony Blair’s new book offers hard-earned lessons to pass along

OpinionBY MARK JOHNSON

Generosity delivered: federal government must extend the donation deadline due to postal strike

OpinionBY CONNIE CôTé, KATE HIGGINS, BRUCE MACDONALD

Note to Trudeau: do not fire your most senior minister by Zoom

OpinionBY SHEILA COPPS

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

OpinionBY ANDREA SEALE, DOUG ROTH

Pharmacare bill offers too much ambiguity and too little ambition

OpinionBY CHRIS BONNETT

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Multi-payer pharmacare will fail Canadians

OpinionBY STEVE MORGAN

Liberals ‘dragging their heels’ on pharmacare as COVID ups the need for affordable meds, says labour union, NDP

NewsBY JESSE CNOCKAERT

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

OpinionBY ANDREA SEALE, DOUG ROTH

An expanded pharmacare framework offers a lifeline for millions of people in Canada. It is time for federal, provincial, and territorial governments to deliver it.

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

OpinionBY ANDREA SEALE, DOUG ROTH

An expanded pharmacare framework offers a lifeline for millions of people in Canada. It is time for federal, provincial, and territorial governments to deliver it.

Pharmacare bill offers too much ambiguity and too little ambition

OpinionBY CHRIS BONNETT

To understand and maximize value, we should know why the government chose this odd-duck model, and diabetes and contraception drugs over others. Politics over public health, perhaps?

Pharmacare bill offers too much ambiguity and too little ambition

OpinionBY CHRIS BONNETT

To understand and maximize value, we should know why the government chose this odd-duck model, and diabetes and contraception drugs over others. Politics over public health, perhaps?

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.

Multi-payer pharmacare will fail Canadians

OpinionBY STEVE MORGAN

Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.

Multi-payer pharmacare will fail Canadians

OpinionBY STEVE MORGAN

Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.

Liberals ‘dragging their heels’ on pharmacare as COVID ups the need for affordable meds, says labour union, NDP

NewsBY JESSE CNOCKAERT

Liberals ‘dragging their heels’ on pharmacare as COVID ups the need for affordable meds, says labour union, NDP

NewsBY JESSE CNOCKAERT

The building blocks of drug coverage reforms in Canada

In the fragmented system, we don't even have access to data on prescribed drugs to assess if physicians’ prescribing habits are in line with best medical evidence, or if they are simply the results of drug companies’ promotional campaigns.

Chrystia Freeland’s resignation changes nothing

A unique research and innovation partnership celebrates three decades: South Africa and Canada move forward with a renewed vision

Tony Blair’s new book offers hard-earned lessons to pass along

Generosity delivered: federal government must extend the donation deadline due to postal strike

Note to Trudeau: do not fire your most senior minister by Zoom

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

Pharmacare bill offers too much ambiguity and too little ambition

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

Multi-payer pharmacare will fail Canadians

Liberals ‘dragging their heels’ on pharmacare as COVID ups the need for affordable meds, says labour union, NDP

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

Feds must expand pharmacare to include essential drugs for our deadliest diseases: cancer, heart conditions, and stroke

Pharmacare bill offers too much ambiguity and too little ambition

Pharmacare bill offers too much ambiguity and too little ambition

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

Multi-payer pharmacare will fail Canadians

Multi-payer pharmacare will fail Canadians

Liberals ‘dragging their heels’ on pharmacare as COVID ups the need for affordable meds, says labour union, NDP

Liberals ‘dragging their heels’ on pharmacare as COVID ups the need for affordable meds, says labour union, NDP

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Follow us

Advertise

subscribe

get help

Get free news updates

Submit a guest opinion article

The building blocks of drug coverage reforms in Canada

In the fragmented system, we don't even have access to data on prescribed drugs to assess if physicians’ prescribing habits are in line with best medical evidence, or if they are simply the results of drug companies’ promotional campaigns.

Get The Policy Briefings Newsletter